TFEB and melanoma: Recently, an important property distinguishing SB202190 from BIRB796 was identified: a SB202190-specific, p38-independent ability to robustly translocate lysosomal membrane-bound TFEB, a MITF-related protein, to the nucleus of melanoma cells [48].